Fourteen patients with multiple myeloma have been treated with phosphate supplements given orally or intravenously. In all of the seven patients with hypercalcemia, serum calcium was reduced into the normal range and maintained at that level as long as phosphate supplementation was continued. Hypercalciuria was likewise reduced by administration of phosphate, even in the absence of hypercalcemia. All patients experienced some relief of pain, and five became symptom-free. No significant complications of phosphate supplementation were observed.
Goldsmith RS, Bartos H, Hulley SB, Ingbar SH, Moloney WC. Phosphate Supplementation as an Adjunct in the Therapy of Multiple Myeloma. Arch Intern Med. 1968;122(2):128–133. doi:10.1001/archinte.1968.00300070032006
Customize your JAMA Network experience by selecting one or more topics from the list below.